🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
OnKure Therapeutics, Inc. (OKUR)
NASDAQ: OKUR · Real-Time Price · USD
2.760
-0.060 (-2.13%)
At close: Nov 19, 2026, 4:00 PM EST
2.630
-0.130 (-4.71%)
After-hours: Nov 19, 2026, 6:19 PM EST

OnKure Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Selling, General & Admin
15.8914.6910.374.823.9
Research & Development
50.148.2643.1732.1225.86
Operating Expenses
65.9962.9553.5436.9329.77
Operating Income
-65.99-62.95-53.54-36.93-29.77
Interest Expense
-0.01-0.01-0.15--
Interest & Investment Income
4.143.442.011.620.25
Other Non Operating Income (Expenses)
---0.04--
EBT Excluding Unusual Items
-61.85-59.52-51.71-35.31-29.51
Merger & Restructuring Charges
---0.23--
Other Unusual Items
---0.74--
Pretax Income
-61.85-59.52-52.67-35.31-29.51
Net Income
-61.85-59.52-52.67-35.31-29.51
Net Income to Common
-61.85-59.52-52.67-35.31-29.51
Net Income Growth
-----
Shares Outstanding (Basic)
321430-
Shares Outstanding (Diluted)
321430-
Shares Change
139.12%292.10%1114.54%--
EPS (Basic)
-1.94-4.40-15.28-124.41-
EPS (Diluted)
-1.94-4.40-15.28-124.41-
EPS Growth
-----

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Free Cash Flow
-47.94-51.87-51.17-34.79-28.09
Free Cash Flow Per Share
-1.50-3.84-14.84-122.59-
EBITDA
-65.64-62.5-53.08-36.52-29.54
D&A For EBITDA
0.350.450.460.420.23
EBIT
-65.99-62.95-53.54-36.93-29.77
SEC Filings: 10-K · 10-Q